This site is intended only for healthcare professionals resident in India

Search

Menu

Close

Sign InLog Out
Our medicinesTherapy areasExplore ContentExplore contentMaterialsVideosLet's connectLet's ConnectPfizer medical information
Efficacy & SafetyAboutEfficacy & SafetyPatient SupportAboutAboutCommitment to the GH CommunityIndication & DosingIndication & DosingAdultsChildren

Menu

Close

Efficacy & SafetyAdultAdult Growth Hormone DeficiencyChildrenSmall for Gestational AgeTurner SyndromePrader-Willi SyndromeChronic Renal Insufficiency
Pediatric Growth Hormone Deficiency
Idiopathic Short Stature
DevicesPenPen PresentationHow to Use the PenGoQuickGoQuick PresentationHow to Use GoQuickPatient SupportPatient SupportGroAssistBranded Patient Information LeafletsEducational SupportEducational SupportPrescribing InformationWebinarsEventsMaterialsVideos
ChildrenChiChiAdultC

GoQuick Presentation

Genotropin® GoQuick: Multi-dose disposable penpre-filled, multi-dose, disposable device that is simple to prepare

   

The GoQuick device is designed to meet individual dosing requirements and to suit the patient needs.

   

   

GoQuick is available in 2 presentations, 5.3 and 12 mg, and comes in 2 different colours. This helps patients to quickly identify and check that they have been dispensed the correct dosage.

Blue GoQuick Pen: 5.3 mg
Purple GoQuick Pen: 12 mg

All GoQuick pens are prepared and used in the same way.
​​​​​​​
Please refer to the Genotropin® Local Product Document for information on dosing for different indications.

   

Designed for ease of use1,2


Benefits

Pre-filled and disposable

  • No cartridge loading avoids complicated steps and saves time.
  • No cartridge loading simplifies the process of training patients.
  • Simple step-by-step reconstitution of product (twist from A to B to C).

Pre-settable dosing

  • Allows the correct dose to be given every time.
  • Gives patients reassurance that the correct dose is being administered, regardless of who is injecting.
  • Gives prescriber confidence that the correct dose is given every time, regardless of who is injecting.
  • No daily dose setting reduces injection time and minimises mistakes.
 
Store Genotropin under refrigeration at 2°C to
8°C. Do not freeze. Protect from light.

Storage for one month can take place at
room temperature.
Can be decorated with colorful
stickers to help children feel more
comfortable with their GoQuick®
device.
   Reconstituted Genotropin with preservative
may be stored under refrigeration (2°C to
8°C) for up to 4 weeks protected from light.
Pre-set memory helps ensure the
same correct dose every day.1
    Free accessories supplied at
pharmacy with medication for
patient convenience.

   

Dosing details

   

The following dosing guide will assist prescribers in determining the correct daily dose for patients using the GoQuick Pen:

   

   

   

To know more about the dosing and the procedure refer to the LPD

   

GH, growth hormone.

   

References:
Genotropin. Local product document. Pfizer; 2022. Version LPDSOM052020.European Brand Book Guidelines for growing the Genotropin brand September 2010.

   

PP-GEN-IND-0678 July 2022

Devices

Simplicity and flexibility in administration1

Learn moreLoading
GoQuick
Efficacy & Safety

Proven in different health conditions2-5

Learn moreLoading
Patient Support

Multiple support material

Learn moreLoading
Educational Support

Review the upcoming events

Learn moreLoading
PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out
 
These pages are not intended for patients or for members of the general public. The web pages contain promotional content. For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. Full prescribing information available on request. For more details on, Who is a Registered Medical Practitioner, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April2021.
​​​​​​​
Address: The Capital,  A Wing, 1802, 18th Floor, Plot No. C-70, ‘G’ Block, Bandra Kurla Complex, Bandra East, Mumbai – 400051, India.
 
PP-GEN-IND-0678

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

ButtonButton

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.

Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.

Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.

 
Copyright © 2022 Pfizer Limited, India. All rights reserved. Applicable for Pfizer Products, Product Microsites and Therapy Areas section of the website:
  • All content published herein is intended and strictly only for informational, educational, academic and/or research purposes and shall not be utilized to diagnose or treat a health problem or disease without referring to the full prescribing information for list of approved indications as contained in the product package insert
  • ​​​​​​​While due care and caution has been taken to ensure that the content herein is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information herein
 
For the use of Registered Medical Practitioners only*

These pages are not intended for patients or for members of the general public. The web pages contain promotional content.


If you select 'No', you will be redirected to Pfizer.co.in

For more details on, Who is a Registered Medical Practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
​​​​​​​Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.


PP-UNP-IND-0012 July 2022
Yes No
You are now leaving PfizerPro website
​​​​​​​ ​
​​​​​You are now leaving Pfizer Pro website and will be redirected to another website. Note that you will be governed by the Terms & Conditions and Privacy Policy of the external website. Would you like to continue?

PP-UNP-IND-0012 July 2022


​​​​​​​